Precision BioSciences Inc (DTIL) stock
DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.10+0.05 (+0.71%)
Close on Nov 18, 2026Market cap $195.97MP/E –Yield –
Precision BioSciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Precision BioSciences's market cap was $241.87M on Nov 11, 2026, against $65.73M a year earlier. Over the last 5 years it ranged from $28.50M to $444.65M, with a median of $83.14M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $241.87M | +381.2% |
| 2025 | Dec 31, 2025 | $50.26M | +76.4% |
| 2024 | Dec 31, 2024 | $28.50M | -32.5% |
| 2023 | Dec 29, 2023 | $42.23M | -68.0% |
| 2022 | Dec 30, 2022 | $132.03M | -70.3% |
| 2021 | Dec 31, 2021 | $444.65M | +1.6% |
| 2020 | Dec 31, 2020 | $437.69M | -37.8% |
| 2019 | Dec 31, 2019 | $703.73M | – |
See a number that looks wrong?